Hansen Henrik, Beyer Nina, Frølich Anne, Godtfredsen Nina, Bieler Theresa
Department of Respiratory Medicine, Respiratory Research Unit, Hvidovre University Hospital, Hvidovre, Denmark.
Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Patient Relat Outcome Meas. 2021 Jun 1;12:117-128. doi: 10.2147/PROM.S306352. eCollection 2021.
In patients with COPD, the COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), Hospital Anxiety and Depression Scale (HADS) and EuroQol 5D (EQ-5D-3L) are widely used patient reported outcome measures (PROMs) of respiratory symptoms, anxiety, depression and quality of life. Despite established validity, responsiveness and minimal important change (MIC), the reproducibility and especially important agreement parameters remain unreported in these frequently used PROMs. The aim of this study was to investigate the inter-day test-retest reliability and agreement of the CAT, CCQ, HADS and EQ-5D-3L in patients with severe and very severe COPD (FEV1 <50%) eligible for hospital-based pulmonary rehabilitation.
Fifty patients (22 females, mean [SD] age 67 [9] yrs.; FEV 32[9] %; 6-minute walk distance 347 [102] meters; CAT 21 [6] points; BMI: 26 [6] kg/m) completed the questionnaires (CAT, CCQ, HADS, EQ-5D-3L) in combination with functional performance test instructed by one assessor on test-day one (T1) and by another assessor 7-10 days later on test-day two (T2).
The inter-day test-retest reliability ICC was 0.88 (LL: 0.80) for CAT; 0.69 (LL: 0.46) for CCQ; 0.86 (LL: 0.75) and 0.90 (LL: 0.82) for HADS-anxiety (A) and depression (D) and 0.87 (LL: 0.76) for EQ-5D-VAS. The corresponding agreements within a single measurement (standard error of measurement, SEM) and for repeated measurement errors (smallest real difference, SRD) were respectively 2.1 and 2.9 points for CAT; 0.5 and 0.7 points for CCQ total; 1.3 and 1.9 points for HADS-A; 0.9 and 1.3 points for HADS-D and 6.8 and 9.7 VAS-score for EQ-5D-3L, respectively. Ceiling/flooring effect was present in <5% for all questionnaires.
In patients with severe and very severe COPD, the CAT, CCQ, HADS and EQ-5D-3L questionnaires presented moderate to excellent inter-day test-retest reliability, and no floor or ceiling effect was documented for any of the questionnaires. Only CAT and HADS had an acceptable SRD below the established MIC for assessing change over time on group level, and none of the PROMS were fit to assess individual changes over time.
在慢性阻塞性肺疾病(COPD)患者中,COPD评估测试(CAT)、临床COPD问卷(CCQ)、医院焦虑抑郁量表(HADS)和欧洲五维健康量表(EQ-5D-3L)是广泛使用的患者报告结局指标(PROMs),用于评估呼吸症状、焦虑、抑郁和生活质量。尽管这些指标已被证实具有有效性、反应性和最小重要变化(MIC),但这些常用PROMs的重测信度,尤其是重要一致性参数仍未报告。本研究的目的是调查CAT、CCQ、HADS和EQ-5D-3L在符合住院肺康复条件的重度和极重度COPD(FEV1<50%)患者中的日间重测信度和一致性。
50例患者(22例女性,平均[标准差]年龄67[9]岁;FEV为32[9]%;6分钟步行距离为347[102]米;CAT评分为21[6]分;体重指数:26[6]kg/m²)在测试日1(T1)由一名评估者指导完成问卷(CAT、CCQ、HADS、EQ-5D-3L)及功能测试,并在7-10天后的测试日2(T2)由另一名评估者指导重复进行。
CAT的日间重测信度组内相关系数(ICC)为0.88(下限:0.80);CCQ为0.69(下限:0.46);HADS焦虑(A)和抑郁(D)分量表分别为0.86(下限:0.75)和0.90(下限:0.82);EQ-5D视觉模拟量表(VAS)为0.87(下限:0.76)。单次测量的相应一致性(测量标准误,SEM)和重复测量误差(最小实际差异,SRD)分别为:CAT为2.1分和2.9分;CCQ总分0.5分和0.7分;HADS-A为1.3分和1.9分;HADS-D为0.9分和1.3分;EQ-5D-3L为6.8分和9.7分。所有问卷的天花板/地板效应均<5%。
在重度和极重度COPD患者中,CAT、CCQ、HADS和EQ-5D-3L问卷呈现出中度至优秀的日间重测信度,且所有问卷均未记录到地板或天花板效应。只有CAT和HADS在评估组水平上随时间的变化时,其SRD低于既定的MIC,且没有一个PROM适合评估个体随时间的变化。